Table: Kobayashi Pharmaceutical -Q1 group results
Apr 28 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2020 Mar 31, 2019 Dec 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 31.91 31.68 165.00
(+0.7 pct) (+4.2 pct)
Operating 4.88 5.15 26.40
(-5.3 pct) (+2.9 pct)
Recurring 5.04 5.22 28.00
(-3.4 pct) (+0.5 pct)
Net 3.74 3.68 20.00
(+1.6 pct) (+4.5 pct)
EPS 47.89 yen 46.65 yen 255.88 yen
Ann Div 73.00 yen 75.00 yen
-Q2 div 33.00 yen 34.00 yen
-Q4 div 40.00 yen 41.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows